Global Mefenamic Acid Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: Apr-2021 | Id: MACRC-48566 | Geographical Scope: Global | Publisher: HNY Research
The global Mefenamic Acid market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Shionogi Pharma Solitaire Pharmacia Shinto Organics Captab EMS Pharma Adelco Agron Remedies IASIS Pharmaceuticals Hellas ABL Lifecare Farmo Quimica Apotex Sanofi Aventis Yung Sine Streuli Pharma, Mankind Pfizer Daiichi Sankyo Chemidex Pharma AA Pharma Nisshin Pharmaceutical Koa Isei Teva Wockhardt Esteve By Types: Patent Generic By Applications: Hospital Drug Store On-line Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Mefenamic Acid Revenue 1.5 Market Analysis by Type 1.5.1 Global Mefenamic Acid Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Patent 1.5.3 Generic 1.6 Market by Application 1.6.1 Global Mefenamic Acid Market Share by Application: 2022-2027 1.6.2 Hospital 1.6.3 Drug Store 1.6.4 On-line 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Mefenamic Acid Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Mefenamic Acid Market Players Profiles 3.1 Shionogi Pharma 3.1.1 Shionogi Pharma Company Profile 3.1.2 Shionogi Pharma Mefenamic Acid Product Specification 3.1.3 Shionogi Pharma Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Solitaire Pharmacia 3.2.1 Solitaire Pharmacia Company Profile 3.2.2 Solitaire Pharmacia Mefenamic Acid Product Specification 3.2.3 Solitaire Pharmacia Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Shinto Organics 3.3.1 Shinto Organics Company Profile 3.3.2 Shinto Organics Mefenamic Acid Product Specification 3.3.3 Shinto Organics Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Captab 3.4.1 Captab Company Profile 3.4.2 Captab Mefenamic Acid Product Specification 3.4.3 Captab Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 EMS Pharma 3.5.1 EMS Pharma Company Profile 3.5.2 EMS Pharma Mefenamic Acid Product Specification 3.5.3 EMS Pharma Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 Adelco 3.6.1 Adelco Company Profile 3.6.2 Adelco Mefenamic Acid Product Specification 3.6.3 Adelco Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Agron Remedies 3.7.1 Agron Remedies Company Profile 3.7.2 Agron Remedies Mefenamic Acid Product Specification 3.7.3 Agron Remedies Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 IASIS Pharmaceuticals Hellas 3.8.1 IASIS Pharmaceuticals Hellas Company Profile 3.8.2 IASIS Pharmaceuticals Hellas Mefenamic Acid Product Specification 3.8.3 IASIS Pharmaceuticals Hellas Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 ABL Lifecare 3.9.1 ABL Lifecare Company Profile 3.9.2 ABL Lifecare Mefenamic Acid Product Specification 3.9.3 ABL Lifecare Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 Farmo Quimica 3.10.1 Farmo Quimica Company Profile 3.10.2 Farmo Quimica Mefenamic Acid Product Specification 3.10.3 Farmo Quimica Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.11 Apotex 3.11.1 Apotex Company Profile 3.11.2 Apotex Mefenamic Acid Product Specification 3.11.3 Apotex Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.12 Sanofi Aventis 3.12.1 Sanofi Aventis Company Profile 3.12.2 Sanofi Aventis Mefenamic Acid Product Specification 3.12.3 Sanofi Aventis Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.13 Yung Sine 3.13.1 Yung Sine Company Profile 3.13.2 Yung Sine Mefenamic Acid Product Specification 3.13.3 Yung Sine Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.14 Streuli Pharma, 3.14.1 Streuli Pharma, Company Profile 3.14.2 Streuli Pharma, Mefenamic Acid Product Specification 3.14.3 Streuli Pharma, Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.15 Mankind 3.15.1 Mankind Company Profile 3.15.2 Mankind Mefenamic Acid Product Specification 3.15.3 Mankind Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.16 Pfizer 3.16.1 Pfizer Company Profile 3.16.2 Pfizer Mefenamic Acid Product Specification 3.16.3 Pfizer Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.17 Daiichi Sankyo 3.17.1 Daiichi Sankyo Company Profile 3.17.2 Daiichi Sankyo Mefenamic Acid Product Specification 3.17.3 Daiichi Sankyo Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.18 Chemidex Pharma 3.18.1 Chemidex Pharma Company Profile 3.18.2 Chemidex Pharma Mefenamic Acid Product Specification 3.18.3 Chemidex Pharma Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.19 AA Pharma 3.19.1 AA Pharma Company Profile 3.19.2 AA Pharma Mefenamic Acid Product Specification 3.19.3 AA Pharma Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.20 Nisshin Pharmaceutical 3.20.1 Nisshin Pharmaceutical Company Profile 3.20.2 Nisshin Pharmaceutical Mefenamic Acid Product Specification 3.20.3 Nisshin Pharmaceutical Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.21 Koa Isei 3.21.1 Koa Isei Company Profile 3.21.2 Koa Isei Mefenamic Acid Product Specification 3.21.3 Koa Isei Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.22 Teva 3.22.1 Teva Company Profile 3.22.2 Teva Mefenamic Acid Product Specification 3.22.3 Teva Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.23 Wockhardt 3.23.1 Wockhardt Company Profile 3.23.2 Wockhardt Mefenamic Acid Product Specification 3.23.3 Wockhardt Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.24 Esteve 3.24.1 Esteve Company Profile 3.24.2 Esteve Mefenamic Acid Product Specification 3.24.3 Esteve Mefenamic Acid Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Mefenamic Acid Market Competition by Market Players 4.1 Global Mefenamic Acid Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Mefenamic Acid Revenue Market Share by Market Players (2016-2021) 4.3 Global Mefenamic Acid Average Price by Market Players (2016-2021) 5 Global Mefenamic Acid Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Mefenamic Acid Market Size (2016-2021) 5.1.2 Mefenamic Acid Key Players in North America (2016-2021) 5.1.3 North America Mefenamic Acid Market Size by Type (2016-2021) 5.1.4 North America Mefenamic Acid Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Mefenamic Acid Market Size (2016-2021) 5.2.2 Mefenamic Acid Key Players in East Asia (2016-2021) 5.2.3 East Asia Mefenamic Acid Market Size by Type (2016-2021) 5.2.4 East Asia Mefenamic Acid Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Mefenamic Acid Market Size (2016-2021) 5.3.2 Mefenamic Acid Key Players in Europe (2016-2021) 5.3.3 Europe Mefenamic Acid Market Size by Type (2016-2021) 5.3.4 Europe Mefenamic Acid Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Mefenamic Acid Market Size (2016-2021) 5.4.2 Mefenamic Acid Key Players in South Asia (2016-2021) 5.4.3 South Asia Mefenamic Acid Market Size by Type (2016-2021) 5.4.4 South Asia Mefenamic Acid Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Mefenamic Acid Market Size (2016-2021) 5.5.2 Mefenamic Acid Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Mefenamic Acid Market Size by Type (2016-2021) 5.5.4 Southeast Asia Mefenamic Acid Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Mefenamic Acid Market Size (2016-2021) 5.6.2 Mefenamic Acid Key Players in Middle East (2016-2021) 5.6.3 Middle East Mefenamic Acid Market Size by Type (2016-2021) 5.6.4 Middle East Mefenamic Acid Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Mefenamic Acid Market Size (2016-2021) 5.7.2 Mefenamic Acid Key Players in Africa (2016-2021) 5.7.3 Africa Mefenamic Acid Market Size by Type (2016-2021) 5.7.4 Africa Mefenamic Acid Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Mefenamic Acid Market Size (2016-2021) 5.8.2 Mefenamic Acid Key Players in Oceania (2016-2021) 5.8.3 Oceania Mefenamic Acid Market Size by Type (2016-2021) 5.8.4 Oceania Mefenamic Acid Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Mefenamic Acid Market Size (2016-2021) 5.9.2 Mefenamic Acid Key Players in South America (2016-2021) 5.9.3 South America Mefenamic Acid Market Size by Type (2016-2021) 5.9.4 South America Mefenamic Acid Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Mefenamic Acid Market Size (2016-2021) 5.10.2 Mefenamic Acid Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Mefenamic Acid Market Size by Type (2016-2021) 5.10.4 Rest of the World Mefenamic Acid Market Size by Application (2016-2021) 6 Global Mefenamic Acid Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Mefenamic Acid Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Mefenamic Acid Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Mefenamic Acid Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Mefenamic Acid Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Mefenamic Acid Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Mefenamic Acid Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Mefenamic Acid Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Mefenamic Acid Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Mefenamic Acid Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Mefenamic Acid Consumption by Countries 7 Global Mefenamic Acid Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Mefenamic Acid (2022-2027) 7.2 Global Forecasted Revenue of Mefenamic Acid (2022-2027) 7.3 Global Forecasted Price of Mefenamic Acid (2022-2027) 7.4 Global Forecasted Production of Mefenamic Acid by Region (2022-2027) 7.4.1 North America Mefenamic Acid Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Mefenamic Acid Production, Revenue Forecast (2022-2027) 7.4.3 Europe Mefenamic Acid Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Mefenamic Acid Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Mefenamic Acid Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Mefenamic Acid Production, Revenue Forecast (2022-2027) 7.4.7 Africa Mefenamic Acid Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Mefenamic Acid Production, Revenue Forecast (2022-2027) 7.4.9 South America Mefenamic Acid Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Mefenamic Acid Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Mefenamic Acid by Application (2022-2027) 8 Global Mefenamic Acid Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Mefenamic Acid by Country 8.2 East Asia Market Forecasted Consumption of Mefenamic Acid by Country 8.3 Europe Market Forecasted Consumption of Mefenamic Acid by Countriy 8.4 South Asia Forecasted Consumption of Mefenamic Acid by Country 8.5 Southeast Asia Forecasted Consumption of Mefenamic Acid by Country 8.6 Middle East Forecasted Consumption of Mefenamic Acid by Country 8.7 Africa Forecasted Consumption of Mefenamic Acid by Country 8.8 Oceania Forecasted Consumption of Mefenamic Acid by Country 8.9 South America Forecasted Consumption of Mefenamic Acid by Country 8.10 Rest of the world Forecasted Consumption of Mefenamic Acid by Country 9 Global Mefenamic Acid Sales by Type (2016-2027) 9.1 Global Mefenamic Acid Historic Market Size by Type (2016-2021) 9.2 Global Mefenamic Acid Forecasted Market Size by Type (2022-2027) 10 Global Mefenamic Acid Consumption by Application (2016-2027) 10.1 Global Mefenamic Acid Historic Market Size by Application (2016-2021) 10.2 Global Mefenamic Acid Forecasted Market Size by Application (2022-2027) 11 Global Mefenamic Acid Manufacturing Cost Analysis 11.1 Mefenamic Acid Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Mefenamic Acid 12 Global Mefenamic Acid Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Mefenamic Acid Distributors List 12.3 Mefenamic Acid Customers 12.4 Mefenamic Acid Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000